Global Bone Marrow Transplant Market 2018-2027: Analysis & Trends - ResearchAndMarkets.com

November 27, 2018

DUBLIN--(BUSINESS WIRE)--Nov 27, 2018--The “Global Bone Marrow Transplant Market Analysis & Trends - Industry Forecast to 2027” report has been added to ResearchAndMarkets.com’s offering.

The Global Bone Marrow Transplant Market is poised to grow strong during the forecast period 2017 to 2027. Some of the prominent trends that the market is witnessing include newer application of bone marrow transplant, growing number of registry and online services in treatments.

Based on indication, the market is divided into blood disorders and blood cancer. The blood disorders are sub divided into thalassic, sickle cell anemia and plastic anemia. Blood cancer segment, is further is classified into yeoman, solid tumors, acute leukemia, melodramatic syndrome, Mellor neoplasm’s and lymphoma. In addition, Lymphoma include Hodgkin lymphoma and nonworking lymphoma.

Considering transplant type, the market is fragmented into allergenic bone marrow transplant and tautologies bone marrow transplant. By end user, the market is segmented into hospitals, ambulatory surgical centers and multi specialty clinics.

This industry report analyzes the market estimates and forecasts of all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2015, 2016 revenue estimations are presented for 2017 and forecasts from 2018 till 2027.The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the world the report is a valuable asset for the existing players, new entrants and the future investors.The study presents detailed market analysis with inputs derived from industry professionals across the value chain. A special focus has been made on 23 countries such as U.S., Canada, Mexico, U.K., Germany, Spain, France, Italy, China, Brazil, Saudi Arabia, South Africa, etc.

Report Highlights

The report provides a detailed analysis on current and future market trends to identify the investment opportunitiesMarket forecasts till 2027, using estimated market values as the base numbersKey market trends across the business segments, Regions and CountriesKey developments and strategies observed in the marketMarket Dynamics such as Drivers, Restraints, Opportunities and other trendsIn-depth company profiles of key players and upcoming prominent playersGrowth prospects among the emerging nations through 2027Market opportunities and recommendations for new investments

Key Topics Covered

1 Market Outline

1.1 Research Methodology

1.1.1 Research Approach & Sources

1.2 Market Trends

1.3 Regulatory Factors

1.4 End User Analysis

1.5 Strategic Benchmarking

1.6 Opportunity Analysis

2 Executive Summary

3 Market Overview

3.1 Current Trends

3.1.1 Newer application of bone marrow transplant

3.1.2 Growing number of registry

3.1.3 Online services in treatments

3.1.4 Growth Opportunities/Investment Opportunities

3.2 Drivers

3.3 Constraints

3.4 Industry Attractiveness

3.4.1 Bargaining power of suppliers

3.4.2 Bargaining power of buyers

3.4.3 Threat of substitutes

3.4.4 Threat of new entrants

3.4.5 Competitive rivalry

4 Bone Marrow Transplant Market, By Indication

4.1 Blood Disorders

4.1.1 Thalassemia

4.1.2 Sickle cell Anemia

4.1.3 Aplastic Anemia

4.2 Blood Cancer

4.2.1 Myeloma

4.2.2 Solid Tumors

4.2.3 Acute Leukemia

4.2.4 Myelodysplastic Syndrome

4.2.5 Myeloproliferative Neoplasms

4.2.6 Lymphona Hodgkin Lymphoma Non-Hodgkin Lymphoma

5 Bone Marrow Transplant Market, By Transplant Type

5.1 Allogeneic Bone marrow Transplant

5.2 Autologous Bone Marrow Transplant

6 Bone Marrow Transplant Market, By End User

6.1 Hospitals

6.2 Ambulatory Surgical Centers

6.3 Multispecialty Clinics

7 Bone Marrow Transplant Market, By Geography

7.1 North America

7.1.1 US

7.1.2 Canada

7.1.3 Mexico

7.2 Europe

7.2.1 Germany

7.2.2 U.K

7.2.3 Italy

7.2.4 France

7.2.5 Spain

7.2.6 Rest of Europe

7.3 Asia Pacific

7.3.1 China

7.3.2 Japan

7.3.3 India

7.3.4 Australia

7.3.5 New Zealand

7.3.6 Rest of Asia Pacific

7.4 Middle East

7.4.1 Saudi Arabia

7.4.2 UAE

7.4.3 Rest of Middle East

7.5 Latin America

7.5.1 Argentina

7.5.2 Brazil

7.5.3 Rest of Latin America

7.6 Rest of the World (RoW)

7.6.1 South Africa

7.6.2 Others

8 Key Player Activities

8.1 Acquisitions & Mergers

8.2 Agreements, Partnerships, Collaborations and Joint Ventures

8.3 Product Launch & Expansions

8.4 Other Activities

9 Leading Companies

9.1 Hemacare Corporation

9.2 Lonza Group Ltd.

9.3 Merck Millipore Corporation

9.4 Sanofi-Aventis LLC

9.5 AllCells LLC

9.6 STEMCELL Technologies

9.7 American Type Culture Collection (ATCC) Inc.

9.8 Cellular Dynamics International

9.9 PromoCell GmbH

9.10 ReachBio LLC

9.11 Mesoblast Ltd.

9.12 Cruline Inc.

9.13 Lifeline Cell Technology

9.14 Conversant Bio

9.15 Corestem

9.16 BioTime

9.17 Beike Biotechnology

9.18 Gamida Cell

For more information about this report visit https://www.researchandmarkets.com/research/9hpk2x/global_bone?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20181127005380/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Stem Cells



SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 11/27/2018 05:22 AM/DISC: 11/27/2018 05:22 AM


Update hourly